SCOTTSDALE, Ariz., Feb. 10, 2010 (GLOBE NEWSWIRE) -- Health Enhancement Products, Inc. (OTCBB:HEPI) (HEPI) today announced it has retained the services of Kohn & Associates for intellectual property law representation.
Founded in 1995, Kohn & Associates is a group of highly dedicated professionals with diverse scientific and legal acumen. Recognized nationally for their expertise, experience, and effectiveness as a versatile intellectual property law firm, they possess a wealth of experience in the areas of utility and design patents, trademarks, copyrights, opinion work and due diligence, licensing, trade secrets, and litigation.
Kohn & Associates has been internationally recognized as one of the foremost IP firms specializing in biotechnology. As true pioneers in the field, they have been recognized by the National Institutes of Health as one of the top twelve (12) firms worldwide specializing in biotechnology patent prosecution. These rankings were the product not only of their technical expertise in technologies and intellectual property issues, but also based on their proposal for partnering with the NIH in its case management approach.
The Company's biotech clients span the full spectrum of innovative settings: from prestigious research universities and institutions, to Fortune 500 ® corporations, to start-ups. They have represented inventors considered pioneers in their respective scientific disciplines, and successfully prosecuted applications for cutting-edge therapies, treatments, and procedures. A brief list of their representative clients can be found at http://www.kohnandassociates.com/cms--representative-clients.html.
About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. (OTCBB:HEPI) is a health & wellness company engaged in the development of a product comprised of pure, all-natural compounds that can be used as a dietary supplement and food additive. The Company's product is ProAlgaZyme ® (PAZ™) a liquid product drawn from living algae grown in purified water. The water in which the algae are grown is drawn off, filtered and bottled under the trademark ProAlgaZyme ®.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.
For more information, please visit http://www.heponline.com.